Repligen Corporation (United States) is listed on the Nasdaq and has a market capitalization of $9.38 billion, with shareholders equity totaling $2.09 billion.
The company employs approximately 761 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Repligen Corporation reported $197.91 million in revenue, generating net income of $26.63 million.
Key financial metrics include a P/E ratio of 352.15, a price-to-book (P/B) ratio of 4.48, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker RGEN.